Biotech CEO Wants to Fix Canada’s Clinical Trial Problem
Boris Weiss, CEO of Medicare Pharmaceuticals, provides a brief overview of the difficulties to start clinical trials in Canada and his proposed pilot program to alleviate some of those difficulties.
Read More